CAPSTONE INVESTMENT ADVISORS, LLC - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 24 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,177,378
-57.5%
23,393,000
-47.3%
0.07%
-61.4%
Q2 2023$35,708,619
+17.6%
44,393,000
+43.7%
0.18%
+14.3%
Q1 2023$30,367,819
-30.9%
30,893,000
-35.7%
0.15%
-51.9%
Q4 2022$43,959,345
+23.2%
48,043,000
+37.7%
0.32%
+48.8%
Q3 2022$35,685,000
+13.3%
34,900,000
+11.1%
0.22%
+39.6%
Q2 2022$31,494,000
+47.9%
31,400,000
+57.0%
0.15%
+161.0%
Q1 2022$21,290,00020,000,0000.06%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 45,000,000$474,089,0009.50%
ABSOLUTE INVESTMENT ADVISERS, LLC 4,000,000$4,280,0000.96%
DeepCurrents Investment Group LLC 22,150,000$23,650,0000.74%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 19,000,000$19,967,0000.46%
Context Capital Management, LLC 5,750$6,138,0000.40%
WOLVERINE ASSET MANAGEMENT LLC 34,000,000$36,271,0000.35%
Polar Asset Management Partners Inc. 15,000,000$15,993,0000.17%
LINDEN ADVISORS LP 20,000,000$21,281,0000.13%
Wellesley Asset Management 1,599$1,599,0000.11%
Verition Fund Management LLC 6,213,000$6,614,0000.08%
View complete list of TRAVERE THERAPEUTICS INC shareholders